Long-Term Comorbidity Management

Module 6: Long-Term Comorbidity Management

Role of inflammation, functional iron deficiency
- Iron indices interpretation and IV iron protocols
- ESA resistance: inflammation, infection, micronutrient depletion
- Red cell indices and transfusion thresholds
- Role of inflammation, functional iron deficiency
Mineral & Bone Disorders
- Classification and pathophysiology: adynamic disease, osteitis fibrosa
- Diagnostic imaging and bone biopsy indications
- Therapeutic targets: phosphate binders, calcimimetics, PTH control including surgical intervention
Cardiovascular Burden
- Interplay of volume status, vascular calcification, and LV hypertrophy
- Beta-blocker, ACE inhibitor use in HD population
- Arrhythmia surveillance and pacemaker considerations
Multi-system Disease Management and Metabolic Rehabilitation
- Glycemic control strategies for HD-adapted diabetes
- HIV, COVID-19, immunosuppressant pharmacokinetics
- Macronutrient balance and intradialytic hypoglycemia avoidance
- Drug dosing and dialysis clearance: high vs low protein binding agents
- Rehabilitation and physical functioning metrics